首页|期刊导航|中国临床药理学与治疗学|心脏淋巴管生成在心血管疾病中的最新研究进展

心脏淋巴管生成在心血管疾病中的最新研究进展OA

Recent advances of cardiac lymphangiogenesis in cardiovascular dis-ease

中文摘要英文摘要

心脏淋巴管生成在维持组织-液体平衡、免疫反应和脂质吸收中起主要作用,但心脏淋巴重塑受损/过度以及淋巴引流不足与多种心血管疾病的发生有关.本综述重点总结了心脏淋巴管生成的分子调控机制,并剖析其在心血管疾病中的动态作用,也探讨了淋巴-免疫互作机制在心肌组织损伤修复中的影响,以及靶向淋巴管生成在心血管疾病治疗中的潜在价值.淋巴管生成早期可能通过清除代谢废物、减轻水肿促进修复,而慢性期的过度激活或功能障碍则可能加剧纤维化与炎症扩散.因此,深入探究心脏淋巴管生成在心血管疾病中的作用机制,将为开发新的治疗策略提供重要理论依据.

Cardiac lymphatics play a major role in the maintenance of tissue-fluid homeostasis,im-mune response,and lipid uptake.However,im-paired/excessive cardiac lymphatic remodeling and inadequate lymphatic drainage are associated with the development of several cardiovascular diseases(CVDs).This review systematically summarizes the molecular mechanisms of cardiac lymphangiogene-sis and elucidates their dynamic role in CVDs.Mean-while,this article also explores the role of lymphat-ic-immune interactions in the repair process of my-ocardial tissue injury and the potential value of tar-geted lymphangiogenesis in the treatment of CVDs.Early stages of lymphangiogenesis may promote re-pair by removing metabolic waste and reducing edema,whereas hyperactivation or dysfunction in the chronic phase may exacerbate fibrosis and the spread of inflammation.Therefore,an in-depth study of the cardiac lymphangiogenesis in CVDs will provide an important theoretical basis for the de-velopment of new therapeutic strategies.

杨雅坤;樊官伟;李澜

天津中医药大学组分中药国家重点实验室、方剂学教育部重点实验室,天津 301617天津中医药大学组分中药国家重点实验室、方剂学教育部重点实验室,天津 301617天津中医药大学组分中药国家重点实验室、方剂学教育部重点实验室,天津 301617

医药卫生

淋巴管生成心血管疾病调节因子淋巴-免疫治疗策略

lymphangiogenesiscardiovascular diseasesregulatory factorslymphatic-immunetherapeutic strategies

《中国临床药理学与治疗学》 2026 (5)

658-665,8

天津市自然科学基金青年项目(23JCQNJC01070)

10.12092/j.issn.1009-2501.2026.05.010

评论